Health

Results: 853-864 of 8097

Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies

AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis

PR Newswire associated0

Neusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting CT and Other Premium Innovations at RSNA 2025

Perspectum and InHealth Announce National Diagnostics Partnership to Boost Oxford CDC Capacity and Widen Access to Advanced MRI Across the UK

PR Newswire associated0

Ziwig Endotest®: Scientific Validation Published in NEJM Evidence

Heating, injury and health greatest winter concerns for UK families with older loved ones, Elder data reveals

GMA with MOVIVA®

GMA with MOVIVA®: setting new standards in endoscopic bariatric treatment

Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

PR Newswire associated0

Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health